Calamos Advisors’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
Calamos Advisors's GH Position: Q3 2026 in Review
Calamos Advisors increased its Guardant Health (GH) stake by 30% in Q3 2026, buying an estimated $2.32M and bringing the position to 62,131 shares worth $11.1M. The position accounts for 0.03% of the portfolio, ranked #410.
Calamos Advisors first reported a position in GH in Q3 2025 and has held it in 5 quarters since. 670 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- Calamos Advisors held 62,131 shares of Guardant Health worth $11.1M as of Q3 2026.
- Calamos Advisors bought 14,191 Guardant Health shares in Q3 2026, an estimated $2.32M.
- Guardant Health made up 0.03% of Calamos Advisors's portfolio in Q3 2026, its #410 holding.
- Calamos Advisors first reported a position in Guardant Health in Q3 2025 and has held it in 5 quarters since.
- 670 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on Calamos Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.